The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Saved in:
| Title: | The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. |
|---|---|
| Authors: | Fishbein L; From the Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Del Rivero J; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Else T; Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI., Howe JR; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA., Asa SL; Department of Pathology, University Hospitals Cleveland Medical Center and University Health Network, Toronto, Case Western Reserve University, Cleveland, OH., Cohen DL; Renal Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Dahia PLM; Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX., Fraker DL; Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA., Kunz PL; Division of Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT., Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Perrier ND; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Pryma DA; Department of Radiology and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Ryder M; Endocrine Oncology Tumor Group, Division of Medical Oncology, Mayo Clinic, Rochester, MN., Sasson AR; Division of Surgical Oncology, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY., Soulen MC; Department of Radiology, University of Pennsylvania, Philadelphia, PA., Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Pancreas [Pancreas] 2021 Apr 01; Vol. 50 (4), pp. 469-493. |
| Publication Type: | Consensus Statement; Journal Article; Practice Guideline |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8608542 Publication Model: Print Cited Medium: Internet ISSN: 1536-4828 (Electronic) Linking ISSN: 08853177 NLM ISO Abbreviation: Pancreas Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33939658 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fishbein+L%22">Fishbein L</searchLink>; From the Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Del+Rivero+J%22">Del Rivero J</searchLink>; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Else+T%22">Else T</searchLink>; Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.<br /><searchLink fieldCode="AU" term="%22Howe+JR%22">Howe JR</searchLink>; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Asa+SL%22">Asa SL</searchLink>; Department of Pathology, University Hospitals Cleveland Medical Center and University Health Network, Toronto, Case Western Reserve University, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Cohen+DL%22">Cohen DL</searchLink>; Renal Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Dahia+PLM%22">Dahia PLM</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX.<br /><searchLink fieldCode="AU" term="%22Fraker+DL%22">Fraker DL</searchLink>; Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Goodman+KA%22">Goodman KA</searchLink>; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.<br /><searchLink fieldCode="AU" term="%22Hope+TA%22">Hope TA</searchLink>; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Kunz+PL%22">Kunz PL</searchLink>; Division of Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Perez+K%22">Perez K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Perrier+ND%22">Perrier ND</searchLink>; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Pryma+DA%22">Pryma DA</searchLink>; Department of Radiology and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Ryder+M%22">Ryder M</searchLink>; Endocrine Oncology Tumor Group, Division of Medical Oncology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Sasson+AR%22">Sasson AR</searchLink>; Division of Surgical Oncology, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY.<br /><searchLink fieldCode="AU" term="%22Soulen+MC%22">Soulen MC</searchLink>; Department of Radiology, University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Jimenez+C%22">Jimenez C</searchLink>; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228608542%22">Pancreas</searchLink> [Pancreas] 2021 Apr 01; Vol. 50 (4), pp. 469-493. – Name: TypePub Label: Publication Type Group: TypPub Data: Consensus Statement; Journal Article; Practice Guideline – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8608542 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-4828 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208853177%22">08853177 </searchLink><i>NLM ISO Abbreviation: </i>Pancreas <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33939658 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/MPA.0000000000001792 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 469 Titles: – TitleFull: The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fishbein L – PersonEntity: Name: NameFull: Del Rivero J – PersonEntity: Name: NameFull: Else T – PersonEntity: Name: NameFull: Howe JR – PersonEntity: Name: NameFull: Asa SL – PersonEntity: Name: NameFull: Cohen DL – PersonEntity: Name: NameFull: Dahia PLM – PersonEntity: Name: NameFull: Fraker DL – PersonEntity: Name: NameFull: Goodman KA – PersonEntity: Name: NameFull: Hope TA – PersonEntity: Name: NameFull: Kunz PL – PersonEntity: Name: NameFull: Perez K – PersonEntity: Name: NameFull: Perrier ND – PersonEntity: Name: NameFull: Pryma DA – PersonEntity: Name: NameFull: Ryder M – PersonEntity: Name: NameFull: Sasson AR – PersonEntity: Name: NameFull: Soulen MC – PersonEntity: Name: NameFull: Jimenez C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2021 Apr 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1536-4828 Numbering: – Type: volume Value: 50 – Type: issue Value: 4 Titles: – TitleFull: Pancreas Type: main |
| ResultId | 1 |
